Process characterization and viral clearance validation are pivotal studies in biopharmaceutical manufacturing, particularly for monoclonal antibodies (mAbs) produced in mammalian systems, which carry ...
Aim: To demonstrate the potential of in-line nanoparticle size measurements using the NanoFlowSizer (NFS) as a PAT method. To achieve real-time process control by establishing automated regulation of ...
WuXi Biologics (2269.HK), a leading global Contract Research, Development, and Manufacturing Organization (CRDMO), today announced the launch of PatroLabTM, a state-of-the-art digital twin platform ...
Process validation, including process characterization, is a critical step in the successful commercialization of a new biopharmaceutical on its path to commercialization. As the program approaches ...
My name is Mark Staub. I am an application specialist in the Global Applications Group at TA Instruments. I received my Bachelor of Science in chemistry at Gettysburg College and subsequently earned ...
Automated characterization is necessary to close the loop between synthesis and discovery of new materials. Through its award-winning faculty, state-of-the-art facilities, and location, the University ...
InProcess-LSP is a relatively new, dynamic organization launched in 2014. The company combines the expertise and experience of three Process Analytical Technology (PAT) scientists and is based at the ...
Thought LeadersRobert HighamHead of CfAMUniversity of Bolton/Centre for Advanced Manufacturing Granutools is a Belgian company that specializes in powder flow characterization; the University of ...
This workshop will examine manufacturing and characterization capacity in the US for mid-scale production of sufficient quantities of emerging materials to assess the engineering utility of those ...
Matt Taylor is a senior process development associate at KBI Biopharma, where he focuses on the design, optimization, and scale-up of purification processes for biopharmaceutical manufacturing. Matt ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results